Skip to content
Companies

OpZira

Dark adaptation headset for detecting retinal disease

Raised to date

$1.1M

across 1 Form D filing

Investors
6
Last filed
Mar 31, 2026

About

OpZira, Inc. is an ophthalmic medical device company headquartered in Middletown, Pennsylvania, established on September 3, 2025. It was formed when Alcon acquired LumiThera and its Valeda Light Delivery System and LumiThera's diagnostic product lines were spun off to LumiThera shareholders as a standalone company. OpZira sells devices for the early detection and ongoing monitoring of ocular disease, on the premise that earlier detection enables interventions that may slow disease progression. It is led by Clark E. Tedford, PhD, formerly president, CEO and co-founder of LumiThera.

Carries two already-commercialized ophthalmic diagnostic platforms out of LumiThera: a portable, AI-assisted wearable dark adaptometer that removes the need for a dedicated darkroom, and a combined VEP/ERG system that assesses the neuro-visual pathway as well as the retina.

Funding

  • OtherFiled Mar 31, 2026Form D
    $1.1M/ no target

Product

AdaptDx Pro

Ophthalmic diagnostic device

A wearable dark adaptometer headset with built-in AI and eye-tracking that measures how long the retina takes to adapt after light exposure, a functional marker used in assessing retinal health.

  • Wearable headset form factor, no darkroom required
  • Built-in AI for a consistent, guided patient experience
  • Eye-tracking to maintain fixation during the test

Built for

Eyecare professionals — optometry and ophthalmology practices and clinics performing retinal and neuro-visual assessment

People on file